Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. BioCheck Inc
WARNING LETTER
•BioCheck Inc•July 20, 2010

BioCheck Inc – FDA Warning Letter, Jul 20, 2010

Record Details

During a June-July 2010 inspection, the FDA determined BioCheck, Inc. manufactures and distributes in vitro diagnostic devices, including "Research Use Only" and "Investigational Use Only" reagents. The FDA found that product inserts for these reagents included intended use statements, test, preparation, and calculation methods, which classify them as devices under section 201(h) of the Federal Food, Drug, and Cosmetic Act (the Act).

BioCheck was found to be promoting and marketing these devices in violation of the Act. Specific products cited for unapproved diagnostic claims include: 1. **Human Cardiac Specific Fatty Acid-Binding Protein (H-FABP) Enzyme Immunoassay Test Kit:** Marketed for diagnosing acute myocardial infarction (AMI) and as a biomarker for stroke, despite being labeled "For Research Use Only." 2. **Prostate Specific Antigen (PSA) Enzyme Immunoassay Test Kit:** Marketed for assessing response to treatment in prostatic cancer, despite being labeled "For Investigational Use Only." 3. **Carcinoembryonic (CEA) Antigen Enzyme Immunoassay Test Kit:** Marketed for detecting increased levels in various cancers, despite being labeled "For Investigational Use Only." 4. **Rubella IgG Enzyme Immunoassay Test Kit:** Marketed for evaluating serologic status to rubella virus infection and assessing immunity, despite being labeled "For Investigational Use Only."

These products are considered adulterated under

Company
BioCheck Inc
Inspection date
July 20, 2010
Product type
Devices
Office
San Francisco District Office
People
  • Barbara J. Cassens (Director )
  • Darlene B. Almogela
  • Lawton W. Lum (Director of Compliance Branch)
View Company Profile

ID · 27b88eea-336a-4383-b4c1-378ec6a4ae40

Violation Codes8
21 U.S.C. 321(h)21 U.S.C. 351(f)(1)(B)21 U.S.C. 360e(a)21 U.S.C. 360j(g)21 U.S.C. 352(0)21 U.S.C. 360(k)21 CFR 807.81(b)21 CFR 801.4

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore BioCheck Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.